Research Overview: Stenabolic SR9009 5mg Sterling Knight
Stenabolic (SR9009) is a synthetic Rev-ERB agonist developed for advanced laboratory research into circadian rhythm modulation and metabolic pathway analysis. This Sterling Knight formulation delivers precisely 5mg of SR9009 per capsule, enabling researchers to investigate the compound’s interaction with nuclear receptors and its influence on cellular energy metabolism. Laboratory studies examine SR9009’s unique mechanism of action in modulating Rev-ERB proteins, which play crucial roles in regulating circadian clock genes and metabolic processes. Researchers at Stroid UK Shop utilise this compound for comprehensive molecular investigations into energy homeostasis and metabolic regulation pathways.
Laboratory Research Applications
Scientific investigations focus on SR9009’s capacity to influence mitochondrial biogenesis and cellular energy production mechanisms. Research protocols examine the compound’s effects on metabolic rate regulation, fat oxidation processes, and glucose metabolism in controlled laboratory environments. Studies investigate SR9009’s potential to modulate circadian rhythm disruption and its applications in metabolic disorder research. Researchers studying SARMs compounds often compare SR9009’s unique Rev-ERB targeting mechanism with traditional selective androgen receptor modulators. Advanced research examines the compound’s influence on liver metabolism, muscle energy utilisation, and adipose tissue regulation. Scientific teams analyse SR9009’s interaction with clock genes and its potential applications in chronobiology research. Comparative studies with other research compounds help elucidate distinct molecular pathways affected by Rev-ERB agonism.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | SR9009 (Stenabolic) |
| Concentration | 5mg per capsule |
| Form | Capsules |
| Manufacturer | Sterling Knight |
| CAS Number | 1379686-30-2 |
| Molecular Formula | C20H24ClN3O4S |
| Storage | Cool, dry conditions |
Researchers studying metabolic modulation often incorporate SR9009 investigations alongside peptide research programs for comprehensive metabolic pathway analysis.
Research Compliance Statement
Stenabolic SR9009 5mg Sterling Knight is manufactured exclusively for in-vitro research applications and laboratory analysis. This compound is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must comply with all applicable regulations governing research chemical handling and ensure appropriate laboratory safety protocols are maintained throughout all experimental procedures.
